Home » Stocks » Arch Therapeutics

Arch Therapeutics, Inc. (ARTH)

Stock Price: $0.175 USD 0.000 (0.00%)
Updated Oct 16, 2020 3:47 PM EDT - End of day

Stock Price Chart

Key Info

Market Cap 33.78M
Revenue (ttm) n/a
Net Income (ttm) -4.12M
Shares Out 193.05M
EPS (ttm) -0.02
PE Ratio n/a
Forward PE 10.75
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Oct 16, 2020
Last Price $0.175
Previous Close $0.175
Change ($) 0.000
Change (%) 0.00%
Day's Open 0.175
Day's Range 0.172 - 0.175
Day's Volume 71,804
52-Week Range 0.14 - 0.295

More Stats

Market Cap 33.78M
Enterprise Value 32.50M
Earnings Date (est) n/a
Ex-Dividend Date n/a
Shares Outstanding 193.05M
Float 162.53M
EPS (basic) -0.03
EPS (diluted) -0.02
FCF / Share -0.03
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short n/a
Short Ratio n/a
Short % of Float n/a
Beta 0.01
PE Ratio n/a
Forward PE 10.75
P/FCF Ratio n/a
PS Ratio n/a
PB Ratio n/a
Revenue n/a
Operating Income -5.54M
Net Income -4.12M
Free Cash Flow -4.97M
Net Cash 1.29M
Net Cash / Share 0.01
Gross Margin n/a
Operating Margin n/a
Profit Margin n/a
FCF Margin n/a
ROA -99.54%
ROE -1,646.09%
ROIC -1,076.10%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (0)

Buy 0
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: n/a

Price Target

$1.38*
(688.57% upside)
Low
1.25
Current: $0.175
High
1.50
Target: 1.38
*Average 12-month price target from 2 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year201920182017201620152014201320122011
Revenue---------
Operating Income-6.37-7.45-7.30-6.05-5.46-4.61-1.74-0.42-0.01
Net Income-4.55-4.81-7.79-5.99-2.95-8.14-1.85-0.58-0.01
Shares Outstanding16615314312181.3967.4921.375.651.07
Earnings Per Share-0.03-0.03-0.05-0.05-0.04-0.12-0.09-0.10-
Operating Cash Flow-5.27-5.91-5.62-4.75-4.24-3.35-1.43-0.25-
Capital Expenditures--0.02-0.01------
Free Cash Flow-5.27-5.93-5.62-4.75-4.24-3.35-1.43-0.25-
Cash & Equivalents2.184.675.995.043.960.831.560.020.02
Total Debt---0.981.440.960.942.01-
Net Cash / Debt2.184.675.994.062.52-0.120.61-1.990.02
Assets2.904.846.095.144.000.881.590.020.02
Liabilities3.713.483.861.982.467.771.402.79-
Book Value-0.811.362.233.161.54-6.890.19-2.770.01
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Arch Therapeutics, Inc.
Country United States
Employees 8
CEO Terrence W. Norchi

Stock Information

Ticker Symbol ARTH
Stock Exchange US OTC
Sector Healthcare
Industry Biotechnology
Unique Identifier OTCMKTS: ARTH

Description

Arch Therapeutics, together with its subsidiaries, operates as a biotechnology company in the United States. The company develops products based on its technology to stop bleeding and control leaking, as well as manages wounds during surgery, trauma, and interventional care. Its primary product candidate is AC5 Devices, a product containing synthetic biocompatible peptides that comprise naturally occurring amino acids to achieve hemostasis in skin wounds and in minimally invasive and open surgical procedures. The company was founded in 2006 and is based in Framingham, Massachusetts.